Literature DB >> 14871168

Primary blepharospasm: diagnosis and management.

Giovanni Defazio1, Paolo Livrea.   

Abstract

Primary blepharospasm is an adult-onset focal dystonia characterised by involuntary contractions of the orbicularis oculi muscles. Patients may have various types of movements arising from the different parts of the orbicularis oculi muscle. These include typical blepharospasm associated with Charcot's sign, pretarsal blepharospasm and flickering of the eyelids. Primary blepharospasm may be associated with so-called apraxia of eyelid opening as well as dystonia in the lower face, jaw or cervical muscles. Unless there are clinical clues to a symptomatic cause, adults presenting with blepharospasm do not require extensive aetiological investigation because the condition is rarely due to an identifiable condition. As the aetiology of primary blepharospasm is largely unknown, therapeutic approaches are symptomatic, with type A botulinum toxin being the treatment of choice.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14871168     DOI: 10.2165/00003495-200464030-00002

Source DB:  PubMed          Journal:  Drugs        ISSN: 0012-6667            Impact factor:   9.546


  54 in total

1.  Botulinum toxin type B in blepharospasm and hemifacial spasm.

Authors:  C Colosimo; M Chianese; M Giovannelli; M F Contarino; A R Bentivoglio
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-05       Impact factor: 10.154

2.  Pretarsal injections of botulinum toxin improve blephospasm in previously unresponsive patients.

Authors:  L Kowal
Journal:  J Neurol Neurosurg Psychiatry       Date:  1997-10       Impact factor: 10.154

Review 3.  Ophthalmologic causes of blepharospasm.

Authors:  D Pita Salorio; R Quintana Conte
Journal:  Adv Neurol       Date:  1988

Review 4.  Etiology and differential diagnosis of blepharospasm and oromandibular dystonia.

Authors:  J Jankovic
Journal:  Adv Neurol       Date:  1988

5.  The prevalence of primary dystonia in the general community.

Authors:  J Müller; S Kiechl; G K Wenning; K Seppi; J Willeit; A Gasperi; J Wissel; T Gasser; W Poewe
Journal:  Neurology       Date:  2002-09-24       Impact factor: 9.910

6.  Long-term efficacy of local doxorubicin chemomyectomy in patients with blepharospasm and hemifacial spasm.

Authors:  J D Wirtschafter; L K McLoon
Journal:  Ophthalmology       Date:  1998-02       Impact factor: 12.079

7.  Analysis of open-label trials in torsion dystonia using high dosages of anticholinergics and other drugs.

Authors:  P Greene; H Shale; S Fahn
Journal:  Mov Disord       Date:  1988       Impact factor: 10.338

8.  Risk factors for spread of primary adult onset blepharospasm: a multicentre investigation of the Italian movement disorders study group.

Authors:  G Defazio; A Berardelli; G Abbruzzese; V Coviello; F Carella; M T De Berardinis; G Galardi; P Girlanda; S Maurri; M Mucchiut; A Albanese; M Basciani; L Bertolasi; R Liguori; N Tambasco; L Santoro; G Assennato; P Livrea
Journal:  J Neurol Neurosurg Psychiatry       Date:  1999-11       Impact factor: 10.154

9.  Spread of symptoms in idiopathic torsion dystonia.

Authors:  P Greene; U J Kang; S Fahn
Journal:  Mov Disord       Date:  1995-03       Impact factor: 10.338

10.  Botulinum toxin therapy of eye muscle disorders. Safety and effectiveness. American Academy of Ophthalmology.

Authors: 
Journal:  Ophthalmology       Date:  1989-09       Impact factor: 12.079

View more
  9 in total

Review 1.  Botulinum neurotoxin type A free of complexing proteins (XEOMIN) in focal dystonia.

Authors:  Wolfgang H Jost; Jörg Blümel; Susanne Grafe
Journal:  Drugs       Date:  2007       Impact factor: 9.546

2.  Resolution of blepharospasm after chronic subdural haematoma evacuation: A case report.

Authors:  Tomaz Velnar; Janez Ravnik; Gorazd Bunc
Journal:  Wien Klin Wochenschr       Date:  2012-02-15       Impact factor: 1.704

3.  Changes in ocular higher-order aberrations following botulinum toxin treatment in patients with blepharospasm : BTX improves dry eye in patients with BEB.

Authors:  Yoshihiko Isshiki; Hiroto Ishikawa; Osamu Mimura
Journal:  Jpn J Ophthalmol       Date:  2016-08-08       Impact factor: 2.447

4.  The combined treatment with orbital and pretarsal botulinum toxin injections in the management of poorly responsive blepharospasm.

Authors:  Marcello Esposito; A Fasano; C Crisci; R Dubbioso; R Iodice; Lucio Santoro
Journal:  Neurol Sci       Date:  2013-08-15       Impact factor: 3.307

5.  Exploding vs. imploding headache in migraine prophylaxis with Botulinum Toxin A.

Authors:  Moshe Jakubowski; Peter J McAllister; Zahid H Bajwa; Thomas N Ward; Patty Smith; Rami Burstein
Journal:  Pain       Date:  2006-10-25       Impact factor: 7.926

Review 6.  Botulinum toxin A (Dysport®): in dystonias and focal spasticity.

Authors:  Susan J Keam; Victoria J Muir; Emma D Deeks
Journal:  Drugs       Date:  2011-05-28       Impact factor: 11.431

7.  Oxymetazoline hydrochloride ophthalmic solution, 0.1%, boosts the effects of botulinum toxin on blepharospasm: a case series.

Authors:  Jonathan Sung; Alice Song; Michael Song; Julia Song
Journal:  J Med Case Rep       Date:  2022-08-05

8.  Case report: Blepharospasm in peak-dose dyskinesia may benefit from amantadine in Parkinson's disease.

Authors:  Qian-Ya Fan; Xiao-Dong Zhang; Ze-Di Hu; Shi-Shi Huang; Shi-Guo Zhu; Cai-Ping Chen; Xiong Zhang; Jian-Yong Wang
Journal:  Front Neurol       Date:  2022-09-30       Impact factor: 4.086

9.  Smell and taste in idiopathic blepharospasm.

Authors:  Julie Gamain; Thorsten Herr; Robert Fleischmann; Andrea Stenner; Marcus Vollmer; Carsten Willert; Birgitt Veit; Bernhard Lehnert; Jan-Uwe Mueller; Frank Steigerwald; Frank Tost; Martin Kronenbuerger
Journal:  J Neural Transm (Vienna)       Date:  2021-06-28       Impact factor: 3.575

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.